159 related articles for article (PubMed ID: 24569946)
21. Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center.
Bosma NA; Tilley D; Batra A; Cheung WY
Am J Clin Oncol; 2020 Jul; 43(7):531-535. PubMed ID: 32324599
[TBL] [Abstract][Full Text] [Related]
22. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma.
Liu P; Han Y; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Zhou LQ; Yang JL; Yang S; Wen TY; Shi YK
Chin Med J (Engl); 2019 Aug; 132(15):1807-1814. PubMed ID: 31335477
[TBL] [Abstract][Full Text] [Related]
24. Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer.
Wheeler SB; Kuo TM; Durham D; Frizzelle B; Reeder-Hayes K; Meyer AM
N C Med J; 2014; 75(4):239-46. PubMed ID: 25046086
[TBL] [Abstract][Full Text] [Related]
25. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
[TBL] [Abstract][Full Text] [Related]
26. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
27. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.
Shenkier TN; Voss N; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Klimo P; O'Reilly SE; Sutcliffe S; Connors JM
J Clin Oncol; 2002 Jan; 20(1):197-204. PubMed ID: 11773170
[TBL] [Abstract][Full Text] [Related]
28. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
[TBL] [Abstract][Full Text] [Related]
29. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
30. The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.
Hong JY; Hong ME; Choi MK; Kim YS; Chang W; Maeng CH; Park S; Lee SJ; Do IG; Jo JS; Jung SH; Kim SJ; Ko YH; Kim WS
Ann Oncol; 2014 Jan; 25(1):182-8. PubMed ID: 24356628
[TBL] [Abstract][Full Text] [Related]
31. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss L; Melchardt T; Habringer S; Boekstegers A; Hufnagl C; Neureiter D; Hopfinger G; Greil R; Egle A
Ann Oncol; 2014 Jan; 25(1):171-6. PubMed ID: 24299961
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement.
Peng C; Ho J; Bai HX; Huang Y; Huang RY; Yang L
Hematology; 2019 Dec; 24(1):268-275. PubMed ID: 31793408
[No Abstract] [Full Text] [Related]
33. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.
Unger JM; Moseley A; Symington B; Chavez-MacGregor M; Ramsey SD; Hershman DL
JAMA Netw Open; 2018 Aug; 1(4):e181235. PubMed ID: 30646114
[TBL] [Abstract][Full Text] [Related]
34. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
Melén CM; Enblad G; Sonnevi K; Junlén HR; Smedby KE; Jerkeman M; Wahlin BE
Br J Haematol; 2016 Nov; 175(4):614-622. PubMed ID: 27790699
[TBL] [Abstract][Full Text] [Related]
36. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
[TBL] [Abstract][Full Text] [Related]
37. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
[TBL] [Abstract][Full Text] [Related]
38. Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry.
Fowler ME; Kenzik KM; Al-Obaidi M; Harmon C; Giri S; Arora S; Stephenson C; Khushman M; Outlaw D; Bhatia S; Williams GR
J Geriatr Oncol; 2023 May; 14(4):101505. PubMed ID: 37087962
[TBL] [Abstract][Full Text] [Related]
39. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
[TBL] [Abstract][Full Text] [Related]
40. Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes.
Olson RA; Nichol A; Caron NR; Olivotto IA; Speers C; Chia S; Davidson A; Coldman A; Bajdik C; Tyldesley S
Can J Public Health; 2012; 103(1):46-52. PubMed ID: 22338328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
